77 related articles for article (PubMed ID: 38635412)
21. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
22. Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder.
Rizzo MD; Henriquez JE; Blevins LK; Bach A; Crawford RB; Kaminski NE
J Neuroimmune Pharmacol; 2020 Dec; 15(4):780-793. PubMed ID: 32409991
[TBL] [Abstract][Full Text] [Related]
23. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
24. Cannabis as antivirals.
Sea YL; Gee YJ; Lal SK; Choo WS
J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626776
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoids Receptors in COVID-19: Perpetrators and Victims.
Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Batiha GE
Curr Med Chem; 2023; 30(34):3832-3845. PubMed ID: 36043749
[TBL] [Abstract][Full Text] [Related]
26. The Interplay between the Immune and the Endocannabinoid Systems in Cancer.
Braile M; Marcella S; Marone G; Galdiero MR; Varricchi G; Loffredo S
Cells; 2021 May; 10(6):. PubMed ID: 34064197
[TBL] [Abstract][Full Text] [Related]
27. Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review.
Pereira CF; Vargas D; Toneloto FL; Ito VD; Volpato RJ
Rev Bras Enferm; 2022; 75Suppl 1(Suppl 1):e20201374. PubMed ID: 35262598
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders.
Ahmed I; Rehman SU; Shahmohamadnejad S; Zia MA; Ahmad M; Saeed MM; Akram Z; Iqbal HMN; Liu Q
Molecules; 2021 Jun; 26(11):. PubMed ID: 34205169
[TBL] [Abstract][Full Text] [Related]
29. Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease.
Preteroti M; Wilson ET; Eidelman DH; Baglole CJ
Respir Res; 2023 Mar; 24(1):95. PubMed ID: 36978106
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?
Sarsembayeva A; Schicho R
Front Oncol; 2023; 13():1296906. PubMed ID: 38074691
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
[No Abstract] [Full Text] [Related]
32. Potential Neuroprotective Effect of Cannabinoids in COVID-19 Patients.
Cortes-Altamirano JL; Yáñez-Pizaña A; Reyes-Long S; Angélica GM; Bandala C; Bonilla-Jaime H; Alfaro-Rodríguez A
Curr Top Med Chem; 2022; 22(16):1326-1345. PubMed ID: 35382723
[TBL] [Abstract][Full Text] [Related]
33. Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
[No Abstract] [Full Text] [Related]
34. Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
Rieder SA; Chauhan A; Singh U; Nagarkatti M; Nagarkatti P
Immunobiology; 2010 Aug; 215(8):598-605. PubMed ID: 19457575
[TBL] [Abstract][Full Text] [Related]
35. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
Anand P; Whiteside G; Fowler CJ; Hohmann AG
Brain Res Rev; 2009 Apr; 60(1):255-66. PubMed ID: 19150370
[TBL] [Abstract][Full Text] [Related]
36. The evolution of cannabinoid receptors in cancer.
Pennant NM; Hinton CV
WIREs Mech Dis; 2023; 15(4):e1602. PubMed ID: 36750231
[TBL] [Abstract][Full Text] [Related]
37. Role of cannabis in inflammatory bowel diseases.
Perisetti A; Rimu AH; Khan SA; Bansal P; Goyal H
Ann Gastroenterol; 2020; 33(2):134-144. PubMed ID: 32127734
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Rossi F; Tortora C; Argenziano M; Di Paola A; Punzo F
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471272
[TBL] [Abstract][Full Text] [Related]
40. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from
Nigro E; Formato M; Crescente G; Daniele A
Molecules; 2021 May; 26(9):. PubMed ID: 34063214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
